PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
18,573,918
Share change
+11,651,190
Total reported value
$243,679,459
Price per share
$13.12
Number of holders
50
Value change
+$153,530,591
Number of buys
48
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q2 2019

As of 30 Jun 2019, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,573,918 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Rock Springs Capital Management LP, Cormorant Asset Management, LP, BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, and DAFNA Capital Management LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.